Tourmaline Bio, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
6.67 |
6.67 |
22.00 |
3.62 |
86.64 |
| Przychód Δ r/r |
0.00% |
inf% |
0.00% |
230.00% |
-83.54% |
2292.75% |
| Przychód (min) |
0.00 |
6.67 |
6.67 |
22.00 |
3.62 |
86.64 |
| Przychód (max) |
0.00 |
6.67 |
6.67 |
22.00 |
3.62 |
86.64 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-82.87 |
-87.36 |
-127.97 |
-180.21 |
-124.04 |
-107.35 |
| Zysk netto % |
-inf% |
-1310.38% |
-1919.50% |
-819.13% |
-3425.66% |
-123.91% |
| EPS (średnia) |
-2.90 |
-3.45 |
-4.15 |
-4.80 |
-4.89 |
-4.24 |
| Liczba analityków (Przychody) |
0 |
7 |
10 |
8 |
6 |
7 |
| Liczba analityków (EPS) |
7 |
7 |
8 |
7 |
5 |
2 |
| symbol |
TRML |
TRML |
TRML |
TRML |
TRML |
TRML |